āĻšā§āĻŽSHTDY âĸ OTCMKTS
add
Sinopharm Group ADR
ā§§ā§§.ā§Ŧā§Ŧ$
⧍ āĻā§āϞ, ⧝:ā§Ģā§Ļ:ā§Šā§Ģ AM GMT -ā§Ē · USD · OTCMKTS · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§§ā§§.ā§ā§Š$
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§§ā§§.ā§Ģā§$ - ā§§ā§§.ā§Ŧā§Ŧ$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§§ā§Ļ.ā§§ā§Š$ - ā§§ā§Ģ.⧍ā§Ŧ$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§Ģā§.ā§ā§ŠāĻļāĻ¤Â āĻā§ HKD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§§ā§Ļ.ā§Ŧā§¨Â āĻšāĻž
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(CNY) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§§ā§Ēā§§.ā§Ŧā§ŦāĻā§ | -ā§Š.ā§Žā§§% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Ŧā§ā§§.ā§Ŧā§§Â āĻā§ | -ā§Ŧ.ā§Ģ⧝% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§§ā§Ēā§Ģ.ā§ā§Ļ āĻā§ | ⧍.ā§Ģ⧝% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ā§§.ā§Ļā§Š | ā§.⧍⧝% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | â | â |
EBITDA | ā§Šā§ā§Ļ.ā§Ēā§Ģ āĻā§ | -ā§Ģ.⧧⧝% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§¨ā§Š.ā§Šā§Ž% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(CNY) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Ēā§Ģ.ā§Šā§ŦāĻļāĻ¤Â āĻā§ | -ā§Šā§¨.ā§Ēā§Ē% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§Ēā§§ā§Ģ.ā§Ļā§ŽāĻā§ | â |
āĻŽā§āĻ āĻĻāĻžā§ | ā§¨ā§Žā§Ģ.ā§¯ā§ŠāĻā§ | â |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ⧧⧍⧝.ā§§ā§ŦāĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§Šā§§ā§¨.ā§Ļā§Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ļ.ā§Ēā§Ģ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§§.⧝ā§Ŧ% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§Š.ā§Žā§Ģ% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(CNY) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§§ā§Ēā§Ģ.ā§ā§Ļ āĻā§ | ⧍.ā§Ģ⧝% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | -ā§Šā§Ē.ā§¨ā§ŽāĻļāĻ¤Â āĻā§ | ⧍ā§.ā§Žā§§% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | ā§Ŧā§§.ā§ā§Ģ āĻā§ | ā§§ā§Ēā§§.ā§Ļ⧝% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | ⧧⧍.ā§Žā§ŽāĻļāĻ¤Â āĻā§ | -ā§Ēā§§.ā§Žā§Ž% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | -⧍ā§Ļ.ā§ā§ŽāĻļāĻ¤Â āĻā§ | ā§§ā§.ā§§ā§Ļ% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| -ā§§ā§Ē.ā§§ā§ŠāĻļāĻ¤Â āĻā§ | â |
āϏāĻŽā§āĻĒāϰā§āĻā§
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51â49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧍ā§Ļā§Ļā§Š
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§§,ā§Ļā§Ž,⧍⧧ā§